Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities
- PMID: 24972275
- PMCID: PMC6271559
- DOI: 10.3390/molecules19078916
Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities
Abstract
A series of 2,4-disubstituted quinazoline derivatives were designed and synthesized. The biological results showed that most of quinazoline derivatives exhibited potent antiproliferative activities against a panel of three tumor cell lines and a good inhibitory effect against the adhesion and migration of human umbilical vein endothelial cells (HUVECs). Among these compounds, 11d was the most potent agent, that also exhibited the highest anti-angiogenesis activities in the chick embryo chorioallantoic membrane (CAM) assay.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities.Eur J Med Chem. 2010 Sep;45(9):3895-903. doi: 10.1016/j.ejmech.2010.05.043. Epub 2010 May 26. Eur J Med Chem. 2010. PMID: 20554355
-
Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.Molecules. 2018 Aug 15;23(8):2047. doi: 10.3390/molecules23082047. Molecules. 2018. PMID: 30111763 Free PMC article.
-
Aurora kinase inhibitor VX‑680 suppresses the proliferation and migration of HUVECs and angiogenesis.Mol Med Rep. 2019 May;19(5):3841-3847. doi: 10.3892/mmr.2019.9996. Epub 2019 Feb 27. Mol Med Rep. 2019. PMID: 30816538
-
The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety.Oncotarget. 2016 Oct 18;7(42):68194-68205. doi: 10.18632/oncotarget.11908. Oncotarget. 2016. PMID: 27626690 Free PMC article.
-
Comparative analysis of the chick embryo area vasculosa and chorioallantoic membrane as experimental models to study angiogenesis and anti-angiogenesis.Pathol Res Pract. 2025 Aug;272:156067. doi: 10.1016/j.prp.2025.156067. Epub 2025 May 31. Pathol Res Pract. 2025. PMID: 40479804 Review.
Cited by
-
Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway.Iran J Basic Med Sci. 2016 Apr;19(4):411-6. Iran J Basic Med Sci. 2016. PMID: 27279985 Free PMC article.
-
Synthesis and three-dimensional quantitative structure-activity relationship study of quinazoline derivatives containing a 1,3,4-oxadiazole moiety as efficient inhibitors against Xanthomonas axonopodis pv. citri.Mol Divers. 2018 Nov;22(4):791-802. doi: 10.1007/s11030-018-9837-0. Epub 2018 May 28. Mol Divers. 2018. PMID: 29808346
-
A quinoline derivative exerts antineoplastic efficacy against solid tumour by inducing apoptosis and anti-angiogenesis both in vitro and in vivo.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul;398(7):9161-9176. doi: 10.1007/s00210-025-03830-8. Epub 2025 Feb 6. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39912901
References
-
- Fong T.A., Shawver L.K., Sun L., Tang C., App H., Powell T.J., Kim Y.H., Schreck R., Wang X., Risau W., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 1999;59:99–106. - PubMed
-
- O’Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328. doi: 10.1016/0092-8674(94)90200-3. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources